Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

14-3-3 eta depletion sensitizes glioblastoma cells to irradiation due to enhanced mitotic cell death

Abstract

14-3-3 proteins have important roles in several cellular processes such as cell cycle progression, the DNA-damage checkpoint and apoptosis. We have shown previously that depleting 14-3-3η, a 14-3-3 isoform, enhances mitotic cell death, and that combining it with microtubule agents is more effective for anticancer therapeutics. In this study, we investigated whether depleting 14-3-3η can be combined with radiotherapy to enhance its therapeutic efficacy. We found that depleting 14-3-3η resulted in a synergistic radiosensitizing effect when combined with radiotherapy in several glioblastoma cell lines, where its specific expression and correlation of its expression level with malignancy have been reported. The radiosensitizing effect was associated with enhanced mitotic cell death by 14-3-3η depletion but not with mitotic catastrophe, which is one of the major cell death mechanisms observed in response to irradiation of most solid tumors. These results suggest that 14-3-3η may be a therapeutic target to overcome radioresistance in glioblastoma.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Aitken A . 14-3-3 proteins: a historic overview. Semin Cancer Biol 2006; 16: 162–172.

    Article  CAS  Google Scholar 

  2. Morrison DK . The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 2009; 19: 16–23.

    Article  CAS  Google Scholar 

  3. Yaffe MB . How do 14-3-3 proteins work?— Gatekeeper phosphorylation and the molecular anvil hypothesis. FEBS Lett 2002; 513: 53–57.

    Article  CAS  Google Scholar 

  4. Kruh GD . Introduction to resistance to anticancer agents. Oncogene 2003; 22: 7262–7264.

    Article  CAS  Google Scholar 

  5. Perona R, Sanchez-Perez I . Control of oncogenesis and cancer therapy resistance. Br J Cancer 2004; 90: 573–577.

    Article  CAS  Google Scholar 

  6. Bernier J, Hall EJ, Giaccia A . Radiation oncology: a century of achievements. Nat Rev Cancer 2004; 4: 737–747.

    Article  CAS  Google Scholar 

  7. Noda SE, El-Jawahri A, Patel D, Lautenschlaeger T, Siedow M, Chakravarti A . Molecular advances of brain tumors in radiation oncology. Semin Radiat Oncol 2009; 19: 171–178.

    Article  Google Scholar 

  8. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97–109.

    Article  Google Scholar 

  9. Quigley MR, Post C, Ehrlich G . Some speculation on the origin of glioblastoma. Neurosurg Rev. 2007; 30: 16–20.

    Article  Google Scholar 

  10. Lee CG, Park GY, Han YK, Lee JH, Chun SH, Park HY et al. Roles of 14-3-3eta in mitotic progression and its potential use as a therapeutic target for cancers. Oncogene 2013; 32: 1560–1569.

    Article  CAS  Google Scholar 

  11. Eriksson D, Stigbrand T . Radiation-induced cell death mechanisms. Tumour Biol 2010; 31: 363–372.

    Article  Google Scholar 

  12. Ha GH, Kim HS, Lee CG, Park HY, Kim EJ, Shin HJ et al. Mitotic catastrophe is the predominant response to histone acetyltransferase depletion. Cell Death Differ 2009; 16: 483–497.

    Article  CAS  Google Scholar 

  13. Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997; 1: 3–11.

    Article  CAS  Google Scholar 

  14. Yang X, Cao W, Lin H, Zhang W, Lin W, Cao L et al. Isoform-specific expression of 14-3-3 proteins in human astrocytoma. J Neurol Sci 2009; 276: 54–59.

    Article  CAS  Google Scholar 

  15. Dutreix M, Cosset JM, Sun JS . Molecular therapy in support to radiotherapy. Mut Res 2010; 704: 182–189.

    Article  CAS  Google Scholar 

  16. Deckbar D, Jeggo PA, Lobrich M . Understanding the limitations of radiation-induced cell cycle checkpoints. Crit Rev Biochem Mol Biol 2011; 46: 271–283.

    Article  CAS  Google Scholar 

  17. Bucher N, Britten CD . G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer 2008; 98: 523–528.

    Article  CAS  Google Scholar 

  18. Castedo M, Perfettini JL, Roumier T, Andreau K, Medema R, Kroemer G . Cell death by mitotic catastrophe: a molecular definition. Oncogene 2004; 23: 2825–2837.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a National Research Foundation grant funded by the National R&D Program through the Dongnam Institute of Radiological & Medical Sciences (DIRAMS) funded by the Ministry of Science, ICT and Future Planning (50597-2013). We thank Dr Jung Ki Kim, Min Young Kim, and Min Su Ju for administrative support.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to K Yang or C G Lee.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Park, GY., Han, J., Han, Y. et al. 14-3-3 eta depletion sensitizes glioblastoma cells to irradiation due to enhanced mitotic cell death. Cancer Gene Ther 21, 158–163 (2014). https://doi.org/10.1038/cgt.2014.11

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/cgt.2014.11

This article is cited by

Search

Quick links